Global Diabetic Neuropathy Market Report 2022: Cutting-Edge Product Development to Shape Sector Moving Forward - ResearchAndMarkets.com
Global diabetic neuropathy market was valued at USD 4.66 billion in 2021, and it is expected to reach a value of USD 8.47 billion by 2028, at a CAGR of 8.9% over the forecast period (2022-2028)
DUBLIN--(BUSINESS WIRE)--Nov 11, 2022--
The "Global Diabetic Neuropathy Market, By Disorder, By Distribution Channel & By Region- Forecast and Analysis 2022-2028" report has been added to ResearchAndMarkets.com's offering.
Global diabetic neuropathy market was valued at USD 4.66 billion in 2021, and it is expected to reach a value of USD 8.47 billion by 2028, at a CAGR of 8.9% over the forecast period (2022-2028).
Diabetic neuropathy is a condition that harms the nerves and is linked to hyperglycemia. People who have had diabetes for a long time are more likely to develop nerve damage throughout their bodies, even though the symptoms of diabetic neuropathies could not be identified at an early stage. In spite of the fact that diabetic neuropathy cannot be treated, it may be managed or prevented with the use of a number of treatment techniques. Regulating bodies are required to approve more items and therapeutic techniques that are connected to the condition due to its intricacy.
